Postoperative Pain
Postoperative Pain Market

Postoperative Pain is an anticipated and temporary increase in background pain that occurs following surgical procedures. It is a type of pain that typically lasts less than a few days to months or pain directly related to soft tissue damage such as a sprained ankle or a paper cut. 


The pain is of short duration, but it gradually resolves as the injured tissues heal. It is further classified as acute or chronic pain based on the duration. 


Postoperative Pain Epidemiology Segmentation


Total number of Postoperative Pain surgical procedures 

• Total Postoperative Pain incident cases 

• Severity-specific Postoperative Pain incident cases 


Postoperative Pain Epidemiological Insights Observed in 2020


• The total number of incident cases of Postoperative Pain in the 7MM was observed to be 66,426,881.

• The number of surgical procedures in the United States were found to be 50,773,111, whereas in EU5 countries they were 16,948,543 and in Japan, it was estimated to be 15,311,947.

• The number of incident cases of Postoperative Pain were observed to be 40,618,489 in the United States.


Postoperative Pain Market Insight


The market size of Postoperative Pain in the United States was found to be USD 2,570 million in 2020.  

Postoperative Pain Market Drivers


• Increased patient pool

• Multimodal therapeutic strategies

• Awareness of the disease

• Research and developmental strategies


Postoperative Pain Market Barriers


• Knowledge and approach towards pain management

• Age-specific treatment (lacks for pediatric and children)

• Ignorance of pain 


Postoperative Pain Emerging Therapies


The emerging drugs in the Postoperative Pain market are:


• CR845/Difelikefalin

• VVZ-149 Injections

• Tramadol IV

• F14 (sustained-release celecoxib)/mdc-CWM (Celecoxib)

• Nefopam hydrochloride and paracetamol

• Co-crystal E-58425 (Tramadol/Celecoxib)

• APP13007

• NTM-001 (Ketorolac Pre-Mixed Bag)

• ACP-044

• NVK-009 (Pregabalin and Acetaminophen)

• TLC590

• MR-107A-01

• TPU-006 (Dexmedetomidine Transdermal System (DMTS))

• SAF312

• OCS-01

• PRF110

• Vocacapsaicin (CA-008)

• Nepafenac PPDS/Nepafenac Evolute, and several others. 


Postoperative Pain Disease Key Players 


The key players working in the Postoperative Pain market are:


• Cara Therapeutics

• Vivozon, Inc.

• Avenue Therapeutics, Inc.

• Arthritis Innovation Corporation/MedinCell

• Unither Pharmaceuticals

• Esteve Pharmaceuticals

• Formosa Pharmaceuticals

• Neumentum Pharmaceuticals

• Acadia Pharmaceuticals Inc.

• Nevakar, Inc.

• Taiwan Liposome Company (TLC)

• Viatris Inc. 

• Teikoku Pharma USA, Inc.

• Novartis Pharmaceuticals

• Oculis

• PainReform LTD

• Concentric Analgesics

• Mati Therapeutics Inc., and several others.